These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 7988433)

  • 1. Hypothalamic-pituitary-adrenal activity during chronic central administration of interleukin-2.
    Hanisch UK; Rowe W; Sharma S; Meaney MJ; Quirion R
    Endocrinology; 1994 Dec; 135(6):2465-72. PubMed ID: 7988433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic brain glucocorticoid receptor blockade enhances the rise in circadian and stress-induced pituitary-adrenal activity.
    van Haarst AD; Oitzl MS; Workel JO; de Kloet ER
    Endocrinology; 1996 Nov; 137(11):4935-43. PubMed ID: 8895366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic stimulation of the hypothalamus-pituitary-adrenal axis in rats by interleukin 1beta: central and peripheral mechanisms.
    van der Meer MJ; Sweep CG; Pesman GJ; Tilders FJ; Hermus AR
    Cytokine; 1996 Dec; 8(12):910-9. PubMed ID: 9050749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of the paraventricular nucleus of the hypothalamus in the alteration of neuroendocrine functions induced by intermittent footshock or interleukin.
    Rivest S; Rivier C
    Endocrinology; 1991 Oct; 129(4):2049-57. PubMed ID: 1655391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of voluntary wheel running on circadian corticosterone release and on HPA axis responsiveness to restraint stress in Sprague-Dawley rats.
    Fediuc S; Campbell JE; Riddell MC
    J Appl Physiol (1985); 2006 Jun; 100(6):1867-75. PubMed ID: 16439512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phasic hyperactivity of the HPA axis resulting from chronic central IL-2 administration.
    Hanisch UK; Rowe W; van Rossum D; Meaney MJ; Quirion R
    Neuroreport; 1996 Nov; 7(18):2883-8. PubMed ID: 9116202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of subdiaphragmatic vagotomy on the noradrenergic and HPA axis activation induced by intraperitoneal interleukin-1 administration in rats.
    Wieczorek M; Dunn AJ
    Brain Res; 2006 Jul; 1101(1):73-84. PubMed ID: 16784727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute stress-induced facilitation of the hypothalamic-pituitary-adrenal axis: evidence for the roles of stressor duration and serotonin.
    Cassano WJ; D'mello AP
    Neuroendocrinology; 2001 Sep; 74(3):167-77. PubMed ID: 11528218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of the dorsomedial hypothalamus in glucocorticoid-mediated feedback inhibition of the hypothalamic-pituitary-adrenal axis.
    Stamper CE; Hennessey PA; Hale MW; Lukkes JL; Donner NC; Lowe KR; Paul ED; Spencer RL; Renner KJ; Orchinik M; Lowry CA
    Stress; 2015 Jan; 18(1):76-87. PubMed ID: 25556980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction between oestrogen and oxytocin on hypothalamic-pituitary-adrenal axis activity.
    Ochedalski T; Subburaju S; Wynn PC; Aguilera G
    J Neuroendocrinol; 2007 Mar; 19(3):189-97. PubMed ID: 17280592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Continuous i.c.v. infusion of brain-derived neurotrophic factor modifies hypothalamic-pituitary-adrenal axis activity, locomotor activity and body temperature rhythms in adult male rats.
    Naert G; Ixart G; Tapia-Arancibia L; Givalois L
    Neuroscience; 2006 May; 139(2):779-89. PubMed ID: 16457953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain nitric oxide synthases in the interleukin-1β-induced activation of hypothalamic-pituitary-adrenal axis.
    Gądek-Michalska A; Tadeusz J; Rachwalska P; Spyrka J; Bugajski J
    Pharmacol Rep; 2012; 64(6):1455-65. PubMed ID: 23406756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic stimulation of the pituitary-adrenal axis in rats by interleukin-1 beta infusion: in vivo and in vitro studies.
    Sweep CG; van der Meer MJ; Hermus AR; Smals AG; van der Meer JW; Pesman GJ; Willemsen SJ; Benraad TJ; Kloppenborg PW
    Endocrinology; 1992 Mar; 130(3):1153-64. PubMed ID: 1311230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leptin inhibition of the hypothalamic-pituitary-adrenal axis in response to stress.
    Heiman ML; Ahima RS; Craft LS; Schoner B; Stephens TW; Flier JS
    Endocrinology; 1997 Sep; 138(9):3859-63. PubMed ID: 9275075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cannabinoid receptor type 1 antagonism significantly modulates basal and loud noise induced neural and hypothalamic-pituitary-adrenal axis responses in male Sprague-Dawley rats.
    Newsom RJ; Osterlund C; Masini CV; Day HE; Spencer RL; Campeau S
    Neuroscience; 2012 Mar; 204():64-73. PubMed ID: 22138156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationships among the behavioral, noradrenergic, and pituitary-adrenal responses to interleukin-1 and the effects of indomethacin.
    Wieczorek M; Dunn AJ
    Brain Behav Immun; 2006 Sep; 20(5):477-87. PubMed ID: 16330180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of hypothalamic-pituitary-adrenal axis responsiveness to stress in a rat model of acute cholestasis.
    Swain MG; Patchev V; Vergalla J; Chrousos G; Jones EA
    J Clin Invest; 1993 May; 91(5):1903-8. PubMed ID: 8387536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostaglandins and interleukin-1beta in the hypothalamic-pituitary-adrenal response to systemic phenylephrine under basal and stress conditions.
    Gadek-Michalska A; Bugajski AJ; Bugajski J
    J Physiol Pharmacol; 2008 Sep; 59(3):563-75. PubMed ID: 18953098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperactivation of the hypothalamo-pituitary-adrenocortical axis in streptozotocin-diabetes is associated with reduced stress responsiveness and decreased pituitary and adrenal sensitivity.
    Chan O; Inouye K; Vranic M; Matthews SG
    Endocrinology; 2002 May; 143(5):1761-8. PubMed ID: 11956158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The 5-hydroxytryptamine2 agonist, (+-)-1-(2,5-dimethoxy-4-bromophenyl)-2-aminopropane stimulates the hypothalamic-pituitary-adrenal (HPA) axis. II. Biochemical and physiological evidence for the development of tolerance after chronic administration.
    Owens MJ; Knight DL; Ritchie JC; Nemeroff CB
    J Pharmacol Exp Ther; 1991 Feb; 256(2):795-800. PubMed ID: 1847213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.